Location
United States, North America
Cheque size
$1M - $5M
Investment Stage
Pre Seed
Seed
Series A
Focus Areas
BioTech
About Investor
Kevin Bitterman is a Partner at Atlas Venture in Massachusetts with a strong focus on biotech investing. He participates in pre-seed, seed, and Series A rounds, typically investing between $1M and $5M. Kevin is known for backing highly innovative life sciences startups with strong scientific rigor. He often works closely with founders to shape company strategy and scientific direction. His investment approach emphasizes breakthrough biology and transformative therapeutic potential. He is a long-term partner for biotech founders building category-defining companies.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.